Comparison of oxybutynin, electrostimulation of the posterior tibial nerve and perineal exercises in the treatment of overactive bladder syndrome
DOI:
https://doi.org/10.1590/1809-2950/17020026022019Keywords:
Overactive Bladder Syndrome, Physiotherapy Modalities, Transcutaneous Electrical StimulationAbstract
The objective of this study was to evaluate the efficacy of perineal exercises, transcutaneous electrostimulation of the posterior tibial nerve (TPTNS) and oxybutynin in women with overactive bladder syndrome, which is the second most common cause of urinary incontinence, with extremely uncomfortable urinary symptoms which impair their quality of life. A total of 65 women were randomized, of whom 57 completed treatment. Three groups were formed: the perineal exercises group, the TPTNS group and the control group, which used oxybutynin. The exercises were performed in groups, in the standing, supine and sitting positions, twice a week in 30-minute sessions, totaling 12 sessions. In the TPTNS group, carried out with 10Hz frequency and 200 microsecond pulse width, a transcutaneous electrode was positioned on the patients’ medial malleolus, and another was positioned 10cm above it. The patients of the control group received 10 mg/day doses of immediate release oxybutynin, divided into two 5mg/day doses for 12 consecutive weeks. Before and after the treatments, the patients’ voiding diary was analyzed, their pelvic floor was functionally evaluated and they were asked to fill in an OAB-V8 quality of life questionnaire. Urge incontinence was reduced by 50%, 70.5% and 41% in the exercises, TPTNS and oxybutynin groups, respectively, and statistical significance was detected for stimulation only. The three treatment modalities were effective for improving quality of life in the short-term therapy, and were statistically similar to each other.
Downloads
References
Pan American Health Organization. Health in the Americas 2012
edition: regional outlook and country profiles. Washington, DC:
Pan American Health Organization; 2012.
World Health Organization. Global status report on
noncommunicable diseases 2014. Geneva: World Health
Organization; 2014.
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde.
Departamento de Análise e Situação de Saúde. Plano de ações
estratégicas para o enfrentamento das doenças crônicas
não transmissíveis (DCNT) no Brasil, 2011-2022. Brasília, DF:
Ministério da Saúde; 2011.
World Health Organization. Fact sheets: noncommunicable
diseases. Geneva: World Health Organization; 2015.
Oliveira JEP, Vencio S, editors. Diretrizes da Sociedade Brasileira
de Diabetes: 2014-2015. São Paulo: AC Farmacêutica; 2015.
World Health Organization. Definition, diagnosis and
classification of diabetes mellitus and its complications: report
of a WHO Consultation. Part 1: diagnosis and classification of
diabetes mellitus. Geneva: World Health Organization; 1999.
American Diabetes Association. Diagnosis and classification
of diabetes mellitus. Diabetes Care. 2013;36(1):S67-74. doi:
2337/dc13-S067
Vukojević Z, Pekmezović T, Nikolić A, Perić S, Basta I, Marjanović,
et al. Correlation of clinical and neurophysiological findings
with health related quality of life in patients with diabetic
polyneuropathy. Vojnosanit Pregl. 2014;71(9):833-8. doi:
2298/VSP120919015V
Mochizuki Y, Tanaka H, Matsumoto K, Sano H, Toki H, Shimoura
H, et al. Association of peripheral nerve conduction in diabetic
neuropathy with subclinical left ventricular systolic dysfunction.
Cardiovasc Diabetol. 2015;14:47. doi: 10.1186/s12933-015-0213-4
Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R,
Kammerer C, et al. Accelerated loss of skeletal muscle strength
in older adults with type 2 diabetes: the health, aging, and
body composition study. Diabetes Care. 2007;30(6):1507-12.
doi: 10.2337/dc06-2537
Sacchetti MS, Balducci S, Bazzucchi I, Carlucci F, Palumbo A,
Haxhi J, et al. Neuromuscular dysfunction in diabetes: role of
motor nerve impairment and training status. Med Sci Sports
Exerc. 2013;45(1):52-9. doi: 10.1249/MSS.0b013e318269f9bb
Orlando G, Balducci S, Bazzucchi I, Pugliese G, Sacchetti M.
Neuromuscular dysfunction in type 2 diabetes: underlying
mechanisms and effect of resistance training. Diabetes Metab
Res Rev. 2016;32(1):40-50. doi: 10.1002/dmrr.2658
Balducci S, Sacchetti M, Orlando G, Salvi L, Pugliese L, Salerno
G, et al. Correlates of muscle strength in diabetes: the study on
the assessment of determinants of muscle and bone strength
abnormalities in diabetes (SAMBA). Nutr Metab Cardiovasc
Dis. 2014;4(1):18-26. doi: 10.1016/j.numecd.2013.04.010
Parmenter BJ, Raymond J, Dinnen PJ, Lusby RJ, Singh
MAF. Preliminary evidence that low ankle-brachial index is
associated with reduced bilateral hip extensor strength and
functional mobility in peripheral arterial disease. J Vasc Surg.
;57(4):963-73. doi: 10.1016/j.jvs.2012.08.103
Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen
H. Accelerated atrophy of lower leg and foot muscles: a followup study of long-term diabetic polyneuropathy using magnetic
resonance imaging (MRI). Diabetologia. 2009;52(6):1182-91.
doi: 10.1007/s00125-009-1320-0
Allen MD, Kimpinski K, Doherty TJ, Rice CL. Decreased muscle
endurance associated with diabetic neuropathy may be
attributed partially to neuromuscular transmission failure. J Appl
Physiol. 2015;118(8):1014-22. doi: 10.1152/japplphysiol.00441.2014
Ijzerman TH, Schaper NC, Melai T, Meijer K, Willems PJB,
Savelberg HHCM. Lower extremity muscle strength is reduced in
people with type 2 diabetes, with and without polyneuropathy,
and is associated with impaired mobility and reduced quality
of life. Diabetes Res Clin Pract. 2012;95(3):345-51. doi: 10.1016/j.
diabres.2011.10.026
Bianchi L, Zuliani G, Volpato S. Physical disability in the elderly
with diabetes: epidemiology and mechanisms. Curr Diab Rep.
;13(6):824-30. doi: 10.1007/s11892-013-0424-6
Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois
JA, Engelgau MM, et al. Diabetes and physical disability among
older U.S. adults. Diabetes Care. 2000;23(9):1272-7. doi: 10.2337/
diacare.23.9.1272
Sayer AA, Dennison EM, Syddall HE, Gilbody HJ, Phillips DIW,
Cooper C. Type 2 diabetes, muscle strength, and impaired
physical function: the tip of the iceberg? Diabetes Care.
;28(10):2541-2. doi: 10.2337/diacare.28.10.2541
Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle
strength in type 2 diabetes. Diabetes. 2004;53(6):1543-8. doi:
2337/diabetes.53.6.1543
Bokan V. Muscle weakness and other late complications of
diabetic polyneuropathy. Acta Clin Croat [Internet]. 2011 [cited
Apr 24];50(3):351-5. Available from: hrcak.srce.hr/84096
Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of
muscle proteins, muscle functions, and amino acid kinetics in
type 2 diabetes. Diabetes. 2002;51(8):2395-404. doi: 10.2337/
diabetes.51.8.2395
Andreassen CS, Jakobsen J, Andersen H. Muscle weakness:
a progressive late complication in diabetic distal symmetric
polyneuropathy. Diabetes. 2006;55(3):806-12. doi: 10.2337/
diabetes.55.03.06.db05-1237
Hawley J, Zierath JR, editors. Physical activity and type 2
diabetes: therapeutic effects and mechanisms of action.
Champaign: Human Kinetics; 2008.
Park SW, Goodpaster BH, Strotmeyer ES, Rekeneire N, Harris
TB, Schwartz AV, et al. Decreased muscle strength and quality
in older adults with type 2 diabetes: the health, aging, and body
composition study. Diabetes. 2006;55(6):1813-8. doi: 10.2337/
db05-1183
Harbo T, Brincks J, Andersen H. Maximal isokinetic and isometric
muscle strength of major muscle groups related to age, body
mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol.
;112(1):267-75. doi: 10.1007/s00421-011-1975-3
Jones EJ, Bishop PA, Woods AK, Green JM. Cross-sectional
area and muscular strength: a brief review. Sports Med.
;38(12):987-94. doi: 10.2165/00007256-200838120-00003
Boshra H, Bahrpeyma F, Tehrani MRM. The comparison of
muscle strength and short term endurance in the different
periods of type 2 diabetes. J Diabetes Metab Disord. 2014;13:22.
doi: 10.1186/2251-6581-13-22
Ijzerman TH, Schaper NC, Melai T, Blijham P, Meijer K, Willems
PJB, et al. Motor nerve decline does not underlie muscle
weakness in type 2 diabetic neuropathy. Muscle Nerve.
;44(2):241-5. doi: 10.1002/mus.22039
Allen MD, Major B, Kimpinski K, Doherty TJ, Rice CL. Skeletal
muscle morphology and contractile function in relation to
muscle denervation in diabetic neuropathy. J Appl Physiol.
;116(5):545-52. doi: 10.1152/japplphysiol.01139.2013
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Fisioterapia e Pesquisa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.